recombinant antibody Flashcards
what is recombinant antibodies
are mono-specific antibodies produced from the recombinant DNA technique
what is the need for recombinant antibodies
- rescue of specificity
- appropriate production of cell line
- humanization
- design of effector function
- functionalization of fragment evolved from phage display
- antibodies generated from isolated cells
why there is need for recombinant antibodies
- to rescue specificity encoded by unstable hybridoma and cell line
- being able to transform mouse antibody into human antibody through in vivo
- designing antibody for function
what is chimeric antibody
is when V domain of mouse antibody is combined by C domain of human antibody
what is CDR grafting antibody
is antibody produced when CDR of mouse is combined with human V domain framework region and C domain
how does humanization occurs
- by chimerization
-CDR grafting - guided selection
what is HAMA (human anti mouse antibody) reaction
is when patient reacted to mouse antibodies as if they are foreign substances
what is the benefit of humanization
reduce HAMA reaction and immunogenicity
what is guided selection
is antibody produced when they select partly human variant in library is combined with one variant of mouse antibody
what problem can humanization cause
immunogenicity is completely avoided because CDR is not only molecule involved in antigen binding so other substance outside the CDR can affect positioning of CDR
can mouse antibody be transformed into human antibody and how
yes, in vivo
what are we looking for in antibody
-binding to cells and kill them after activation of toxin at antibody binding site
- activate other cells at antibody binding site
- target CD8+ T cells to killed cells
- avidity
-Fc receptor binding
-stability on mucosa/IgA
-absence of effector function
-bi-specific antibody
how does T cells kills cells that are affected by virus
T cells kills cells via antibody specificity rather than by TCR
what is Intact antibodies
is a full antibody
what is a fragment
small part of antibody